TWO SIGMA ADVISERS, LP - ENTASIS THERAPEUTICS HLDGS I ownership

ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 30 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ENTASIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q4 2021$369,000
-51.8%
168,700
-26.3%
0.00%
-50.0%
Q3 2021$765,000
+75.9%
229,000
+40.5%
0.00%
+100.0%
Q2 2021$435,000162,9420.00%
Other shareholders
ENTASIS THERAPEUTICS HLDGS I shareholders Q3 2021
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 1,349,953$8,046,0002.52%
Novo Holdings A/S 2,181,843$13,004,0002.23%
Sofinnova Investments, Inc. 1,180,178$7,034,0000.64%
TPG Group Holdings (SBS) Advisors, Inc. 2,041,496$12,168,0000.09%
Eventide Asset Management 392,513$2,288,0000.08%
Blackstone Inc. 1,623,405$9,675,0000.06%
Granahan Investment Management 141,012$840,0000.05%
Janney Montgomery Scott LLC 46,861$279,0000.00%
BANK OF MONTREAL /CAN/ 5,921$35,0000.00%
BlackRock Inc. 15,755$94,0000.00%
View complete list of ENTASIS THERAPEUTICS HLDGS I shareholders